Literature DB >> 11786375

The effect of prenatal betamethasone administration on postnatal ovine hypothalamic-pituitary-adrenal function.

D M Sloboda1, T J Moss, L C Gurrin, J P Newnham, J R G Challis.   

Abstract

Prenatal exposure to glucocorticoids is associated with alterations in fetal growth and endocrine function. However, few studies have examined the effects of clinically relevant doses of glucocorticoids on postnatal hypothalamic-pituitary-adrenal (HPA) function. To determine the effects of maternal or fetal betamethasone administration (0.5 mg/kg maternal or estimated fetal weight) on postnatal HPA function at 6 months and 1 year postnatal age, pregnant ewes were randomized into the following treatment groups: no treatment (n=6); maternal saline (n=6); single maternal betamethasone (M1) (n=6); repeated maternal betamethasone (M4) (n=6); fetal saline (n=5); single fetal betamethasone (n=6) and repeated fetal betamethasone (F4) (n=6). Single injections were given at 104 days of gestation and repeated injections at 104, 111, 118 and 125 days. Lambs were born spontaneously and the ACTH and cortisol responses to i.v. corticotropin-releasing hormone (CRH) (0.5 microg/kg) plus arginine vasopressin (AVP) (0.1 microg/kg) were measured at 6 months and 1 year postnatally. At 6 months postnatal age, neither maternal nor fetal prenatal betamethasone administration altered significantly the ACTH and cortisol responses to CRH+AVP. However, in animals at 1 year postnatal age, a previous single injection of betamethasone to the mother (M1) resulted in significantly elevated basal and stimulated cortisol levels (P<0.05), without significant change in the ACTH response. In contrast, betamethasone administration to the fetus resulted in significantly attenuated ACTH responses to CRH+AVP at 1 year compared with control animals (P<0.05), but these were not associated with any significant changes in basal or stimulated cortisol levels. All control animals exhibited a significant increase in peak ACTH responses to CRH+AVP between 6 months and 1 year postnatal age (P<0.05). After prenatal betamethasone (F4, M4) the difference in peak ACTH response between animals at 6 months and 1 year postnatal age was abolished. We conclude that in sheep between 6 months and 1 year postnatal age, HPA function undergoes developmental changes that are influenced by prenatal glucocorticoid exposure. Furthermore, the effects of glucocorticoid on postnatal HPA responses may vary according to the time in gestation that the steroid was administered, and whether it was given directly into the fetal or maternal compartment.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11786375     DOI: 10.1677/joe.0.1720071

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  30 in total

1.  Developmental regulation of the 5-HT7 serotonin receptor and transcription factor NGFI-A in the fetal guinea-pig limbic system: influence of GCs.

Authors:  Marcus H Andrews; Alice Kostaki; Elaine Setiawan; Lucy McCabe; Dawn Owen; Sonja Banjanin; Stephen G Matthews
Journal:  J Physiol       Date:  2004-01-14       Impact factor: 5.182

2.  The plastic fetal pituitary.

Authors:  Drew V Tortoriello
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

3.  Single course of antenatal steroids did not alter cortisol in preterm infants up to 18 months.

Authors:  Ayala Gover; Susanne Brummelte; Anne R Synnes; Steven P Miller; Rollin Brant; Joanne Weinberg; Ruth E Grunau
Journal:  Acta Paediatr       Date:  2012-02-21       Impact factor: 2.299

Review 4.  Fetal programming of hypothalamo-pituitary-adrenal function: prenatal stress and glucocorticoids.

Authors:  Amita Kapoor; Elizabeth Dunn; Alice Kostaki; Marcus H Andrews; Stephen G Matthews
Journal:  J Physiol       Date:  2006-02-09       Impact factor: 5.182

5.  Transgenerational effects of prenatal nutrient restriction on cardiovascular and hypothalamic-pituitary-adrenal function.

Authors:  Caroline Bertram; Omar Khan; Sunil Ohri; David I Phillips; Stephen G Matthews; Mark A Hanson
Journal:  J Physiol       Date:  2008-02-21       Impact factor: 5.182

6.  Can Placental Corticotropin-Releasing Hormone Inform Timing of Antenatal Corticosteroid Administration?

Authors:  Danielle A Swales; Leah A Grande; Deborah A Wing; Michelle Edelmann; Laura M Glynn; Curt Sandman; Roger Smith; Maria Bowman; Elysia Poggi Davis
Journal:  J Clin Endocrinol Metab       Date:  2019-02-01       Impact factor: 5.958

Review 7.  Glucocorticoids and fetal programming part 1: Outcomes.

Authors:  Vasilis G Moisiadis; Stephen G Matthews
Journal:  Nat Rev Endocrinol       Date:  2014-05-27       Impact factor: 43.330

8.  Multigenerational effects of fetal dexamethasone exposure on the hypothalamic-pituitary-adrenal axis of first- and second-generation female offspring.

Authors:  Nathan M Long; Stephen P Ford; Peter W Nathanielsz
Journal:  Am J Obstet Gynecol       Date:  2012-12-07       Impact factor: 8.661

Review 9.  Effects of antenatal corticosteroids on the hypothalamic-pituitary-adrenocortical axis of the fetus and newborn: experimental findings and clinical considerations.

Authors:  Feizal Waffarn; Elysia Poggi Davis
Journal:  Am J Obstet Gynecol       Date:  2012-06-13       Impact factor: 8.661

10.  Full-term-pregnancy effects of antenatal betamethasone administration on short-term variation as assessed by computerized cardiotocography.

Authors:  Juan Piazze; Kathleen Comalli Dillon; Cerekja Albana
Journal:  J Prenat Med       Date:  2012-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.